Changing Treatment Landscape: Managing Patients with Anemia Associated with Chronic Kidney Disease – A Whiteboard Preceptorship

Target Audience
This educational activity is specifically designed for US-based nephrologists and other healthcare professionals caring for patients with anemia associated with CKD.

Program Overview
This case-based enduring activity will review the mechanisms of action and evidence-based standards of care in chronic kidney disease (CKD) and will benefit clinicians caring for patients with anemia associated with CKD.

Learning Objectives
Upon completion of this activity, participants should be better able to:

Describe the complex pathophysiology of anemia of CKD, including the roles of inflammation, EPO, iron, hypoxia-inducible factor (HIF), and hepcidin.
Discuss the advantages and disadvantages associated with evidence-based standard-of-care therapies for the management of anemia of CKD.
Review the mechanisms of action and clinical profiles of emerging treatment options for the management of anemia of CKD, including those targeting hepcidin and HIF-prolyl hydroxylase.